key: cord-0687692-mp26t36h authors: Saegerman, Claude; Donneau, Anne‐Françoise; Speybroeck, Niko; Diep, Anh Nguyet; Williams, Alexandria; Stamatakis, Lambert; Coppieters, Wouter; Michel, Fabienne; Breuer, Christophe; Dandoy, Margaux; Ek, Olivier; Gourzones, Claire; Schyns, Joey; Goffin, Emeline; Minner, Frédéric; Renault, Véronique; Gillet, Laurent; Bureau, Fabrice title: Repetitive saliva‐based mass screening as a tool for controlling SARS‐CoV‐2 transmission in nursing homes date: 2021-08-17 journal: Transbound Emerg Dis DOI: 10.1111/tbed.14280 sha: 432446deb063d71852d2c69991fa0fada6f374c6 doc_id: 687692 cord_uid: mp26t36h Nursing home (NH) residents and staff have been severely affected by the COVID‐19 pandemic. The aim of this study was to examine the use of weekly saliva RT‐qPCR testing for SARS‐CoV‐2 detection among NH workers as a strategy to control disease transmission within NHs in Belgium. From 16 November to 27 December 2020, a voluntary and anonymous weekly screening was implemented in a cohort of 50,000 workers across 572 NHs in the Walloon region of Belgium to detect asymptomatic cases of SARS‐CoV‐2 via saliva RT‐qPCR testing and using the Diagenode saliva sample collection device. Positive workers were isolated to avoid subsequent infections in residents and other staff. RT‐qPCR testing was based on pooled saliva sampling techniques from three workers, followed by individual testing of each positive or inconclusive pool. The majority of NHs (85%) and 55% of their workers participated. Pooling did not affect sensitivity as it only induced a very decrease in sensitivity estimated as 0.33%. Significant decreases in the prevalence (34.4–13.4%) and incidence of NHs with either single (13.8–2%) or multiple positive workers (3.7–0%) were observed over time. In addition, deaths among NH residents and NH worker absences decreased significantly over time. Weekly saliva RT‐qPCR testing for SARS‐CoV‐2 demonstrated large‐scale feasibility and efficacy in disrupting the chain of transmission. Implementation of this testing strategy in NHs could also be extended to other settings with the aim to control viral transmission for maintaining essential activities. 53% of these occurring in nursing home (NH) residents (Sciensano, 2021a ). In the early second wave of the pandemic (late August 2020), Belgian NHs requested additional support to protect their vulnerable residents due to the severity of clinical symptoms in some patients (severe acute respiratory syndrome) and because the elderly are more severely affected by COVID-19 . Mitigation measures were implemented and consisted of limiting external contacts, respecting physical distancing, room ventilation and using personal protective equipment. In addition, the Government of Wallonia in Belgium performed a voluntary and anonymous longitudinal screening study to examine the benefits of saliva testing for detecting the presence of SARS-CoV-2 among a large cohort of NH workers. Saliva collection is considered a potential alternative to nasopharyngeal sampling because of its technical simplicity. Additionally, it is non-invasive and does not require the procedure to be performed by health care professionals. Thus, saliva testing is of interest for weekly repeated sampling strategies (Czumbel et al., 2020) , such as those proposed for use in Belgian NHs to monitor and control the spread of SARS-CoV-2. Recently, a meta-analysis of saliva testing for SARS-CoV-2 detection reported a sensitivity of 91% (95% CI: 80-99) by quantitative reverse-transcriptase polymerase chain reaction (RT-qPCR), compared with 98% (95% CI: 89-100) when using nasopharyngeal swabs (NPS) (Czumbel et al., 2020) . Moreover, another review reported a non-significant difference in viral loads between nasopharyngeal or sputum and saliva samples (Fakheran et al., 2020) . However, greater variation of viral loads has been observed with NPS compared with those from saliva specimens (Wyllie et al., 2020) . In a cohort study of asymptomatic health care workers (n = 493), 13 tested positive for SARS-CoV-2 through saliva testing. Nine of these were also tested through NPS sampling, of which seven were negative. All 13 health care workers who tested positive through saliva testing were re-confirmed to be infected (Wyllie et al., 2020) . Finally, the pooling of samples (i.e., testing a few samples at once) may allow for the detection of SARS-Cov-2 with sufficient diagnostic accuracy (Lohse et al., 2020; Li et al., 2020; Eberhardt et al., 2020) . The primary aim of this study was to investigate the effectiveness and sensitivity of saliva testing in the detection of SARS-CoV-2 in a cohort of 50,000 workers across 572 Belgian NHs in Wallonia. In addition, this study examined the impact of a weekly saliva testing control strategy on SARS-CoV-2 prevalence and incidence among NH workers. The logistical and organizational system, which aimed to guarantee a short sample delivery time, was based on 13 relay points. This system ensured a smooth interface between NHs, suppliers, logistics operators and the University of Liège COVID-19 laboratory (Appendix S1). Fresh saliva was collected using a sampling device designed by the University of Liège and commercialized by Diagenode (Seraing, Belgium). Instructions for using the sampling kit are found in Appendix S2. The device does not require the intervention of medical personnel and contains an integrated process for viral inactivation. In brief, the saliva device consists in a tube fitted with a funnel that doses the volume of saliva that enters the tube. In the tube, the saliva is mixed with a reagent that permits the inactivation of the SARS-CoV-2. This procedure ensures the safe shipment of the sample and safe manipulation by the laboratory workers subsequently. In the collection device, saliva was diluted to a 1:1 ratio with an extrac- Samples were considered negative when no viral genes could be detected below a Ct value of 37 and when the MS2 internal control was under a Ct value of 30. All individual samples were pooled in threes. If a pool was negative, the status of all associated individual samples was considered negative. If a pool was positive or inconclusive, each associated sample was retested individually. In order to determine the impact of pooling (i.e., pools of three individual samples) on final individual results, a random selection of 501 negative pools were de-pooled and individually tested (n = 1503 samples). Exact binomial distributions were used to derive 95% confidence intervals (95% CI) of prevalence and incidence rates (Petrie & Watson, 2013) . Chi-square and Fisher's exact tests were used to compare frequencies between groups (Petrie & Watson, 2013) . Representativeness was checked by comparing characteristics (region, size or type of NH, i.e., with mono or multi-sites) of partic- ipating versus non-participating NHs using binary or Firth's logistic regression models (Heinze & Schemper, 2002) . Multivariate models were applied using variables with p values < .20 at the univariate stage. Collinearity was checked through backwards elimination of variables (Preux et al., 2005) and Hosmer-Lemeshow goodness of fit testing (Petrie & Watson, 2013) . The relationship between prevalence rate (arcsine transformation) and the odds of a NH presenting with at least one positive test result (herein, referred to as a 'positive NH') per week was assessed using a linear regression and Chi-square test for linear and non-linear trends (Petrie & Watson, 2013) . Incidence was analyzed using negative binomial regressions. Differences in the number of absent workers and deaths over time in Belgian NHs between the regions of Wallonia (in the south) and Flanders (in the north) were analyzed through a time series regression using generalized least squares, allowing for possible autocorrelations (Fox & Weisberg, 2018) . All analyses were performed using Stata SE 14. 2 (StataCorp, 2015) and R (R Core Team, 2013). The alpha level was set to .05. In addition, Quantum GIS (Geographic Information System) version 3.16.2 was used to edit specific maps (QGIS Development Team, 2020). NH participation rates reached 85% during the last 4 weeks of the study period. Most NHs participated in the saliva screening for SARS-CoV-2 detection at least five (N = 256) or six times (N = 145) (Table 1) , with participation rates reaching 26% in the first week (W) and 51-57% in the following weeks. Thus, there was a cumulative 530 participating NHs with an estimated maximum 32,900 active workers. No significant difference was found between participating (N = 530) and non-participating (N = 42) NHs in the saliva screening by region There was a significant linear decrease in the prevalence rates of NHs with at least one positive worker or with at least two positive work- The odds of a positive RT-qPCR result decreased each week at the NH level ( Table 2 ). Cumulative odds were calculated for the whole period (weeks 47-52) and mapped for Wallonia ( Figure 2 ). Week The SARS-CoV-2 incidence rate was determined based on the follow- To examine if there was a decrease in the number of absent NH workers (Figure 3(a) ) and deaths in NH residents (Figure 3(b) ) per region as a function of time, we compared our data with that from available public reports (Sciensano, 2021b) using time series regressions. An Autoregressive Moving Average Model -ARMA (0,1) was selected based on an examination of residual deaths. At first, there were significantly more deaths in Wallonia (beta = .267, p < .001) than in Flanders, which reversed over time (beta = −.002, p = .027). The decrease was more significant in Wallonia (beta = −.011, p < .001). The number of absent workers did not correlate with the autoregressive or moving average patterns in the residuals. There were significantly more absent workers in Wallonia (beta = 70.055, p < .001) than in Flanders, with a significant decrease over time in the number of absent workers in both regions (beta = −1.778, p = .033). However, this F I G U R E 3 Regional trends during second wave in (a) the number of possible or confirmed COVID-19 cases per 1000 absent NH workers, and (b) number of COVID-19 deaths per 1000 NH residents (derived from Sciensano, 2021b) . NH, Nursing home; (a) black line represents Wallonia; grey dash represents Flanders; (b) black bars represent Wallonia, grey bars represent Flanders trend was more pronounced in Wallonia (beta = −4.831, p < .001) than in Flanders (Table 4 ). To our knowledge, the present study is the first large-scale longitudinal study assessing the efficiency of a SARS-CoV-2 control strategy using saliva testing with RT-qPCR and pooled sampling methods. The main principle of the strategy was based on the early detection of SARS-CoV-2 asymptomatic workers and isolation of RT-qPCR positive workers at home for 7 days, followed by an additional seven days of caution. These periods were defined based on previous studies (Sciensano, 2021b) . to the progressively significant decrease in incidence, both for single Finally, available information (Sciensano, 2021b) at the national level was used to explore the benefit of a saliva screening strategy. The main difference in mitigation strategies between Flanders and Wallonia was the weekly SARS-CoV-2 saliva testing, which was only being implemented at a large scale in Wallonia. After the first announcement of the saliva screening study for SARS-CoV-2 and its implementation, the decreasing trend of absent workers due to COVID-19 was more pronounced in Wallonia than in Flanders. One hypothesis for this may be an improvement in confidence towards crisis management among NH workers. In addition, the decrease (slope) in deaths among NH residents was more significant over time in Wallonia than in Flanders. The follow-up of these two parameters -one directly related to the number of NH workers affected by COVID-19, and the other related to the number of NH residents that could be infected by these workers -indicated a strong benefit in a SARS-CoV-2 saliva testing strategy. In addition, mortality statistics on NH residents was available for the first COVID-19 wave (but not for NH worker absences). During the first wave, no difference was observed in the number of deaths per 1000 NH residents between the two regions, as the ratio of this number between Wallonia and Flanders was normally distributed around 1 (p value = .16) (Figure 4) . These observations indicate a beneficial effect of the SARS-CoV-2 saliva testing strategy implemented in Wallonia during the second SARS-CoV-2 wave. In addition, the saliva RT-qPCR testing of workers for SARS-CoV-2 should be also valuable in view of possible further contamination of residents by workers that can be infected by new variants of SARS-CoV-2, as these variants appear to induce disease even in vaccinated elderly people (e.g., Garcia-Beltran et al., 2021; Harvey et al., 2021 The proposed COVID-19 weekly saliva RT-qPCR screening strategy among NH workers, coupled with a secure web-based user interface Guide. The data that support the findings of this study are available from the corresponding author upon request. The study was commissioned by the Government of Wallonia within the framework of a public contract initiated by AViQ, as well as the University of Liège. The study was approved by the Ethical Committee of the University of Liège (reference number: 2021-100). The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. (2020) Saliva as a candidate for COVID-19 diagnostic testing: a meta-analysis Challenges and issues of SARS-CoV-2 pool testing. The Lancet Infectious Diseases Saliva as a diagnostic specimen for detection of SARS-CoV-2 in suspected patients: a scoping review An R Companion to Applied Regression. third edition Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity COVID-19 Genomics UK (COG-UK) Consortium, Peacock, S SARS-CoV-2 variants, spike mutations and immune escape A solution to the problem of separation in logistic regression Clinical characteristics and viral shedding kinetics of 38 asymptomatic patients with coronavirus disease 2019: A retrospective observational study Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. The Lancet Infectious Diseases Statistics for veterinary and animal science est-ce qu'une régression logistique ? R: A language and environment for statistical computer. R Foundation for Statistical Computing Clinical decision support tool for diagnosis of COVID-19 in hospitals Belgium COVID-19 Epidemiological Situation Définition de cas, indications de demande d'un test et déclaration obligatoire de cas COVID-19 Surveillance en maisons de repos et maisons de repos et de soins TX: StataCorp LP, USA. World Health Organization. (2021) WHO Coronavirus (COVID-19) Dashboard Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV Repetitive saliva-based mass screening as a tool for controlling SARS-CoV-2 transmission in nursing homes We gratefully acknowledge the Government of Wallonia for their financial support within the framework of a public contract initiated